Skip to Content
Merck

P8340

Protease Inhibitor Cocktail

DMSO solution, for the inhibition of serine, cysteine, acid proteases and aminopeptidases, for use with mammalian cell and tissue extracts, DMSO solution

Synonym(s):

Protease Inhibitor Mix

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
MFCD00677817
Form:
DMSO solution
Solubility:
water: soluble
Storage temp.:
−20°C

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution

biological source

bovine lung

form

DMSO solution

solubility

water: soluble

storage temp.

−20°C

Quality Level

300

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Ideal for use as a buffer component during sonication, lysis buffer, and RIPA buffer

Provides protection against endogenous enzyme activity in cell and tissue extracts

Biochem/physiol Actions

Inhibits serine, cysteine, and acid proteases, and aminopeptidases.
This mixture contains individual components, including AEBSF at 104 mM, Aprotinin at 80 μM, Bestatin at 4 mM, E-64 at 1.4 mM, Leupeptin at 2 mM and Pepstatin A at 1.5 mM. Each component has specific inhibitory properties. AEBSF and Aprotinin act to inhibit serine proteases, including trypsin, chymotrypsin, and plasmin amongst others. Bestatin inhibits aminpeptidases. E-64 acts against cystein proteases. Leupeptin acts against both serine and cystein proteases. Pepstatin A inhibits acid proteases.

Disclaimer

This cocktail should be stored at -20 °C.

Features and Benefits

Broad-spectrum inhibition: inhibits multiple classes of proteases and aminopeptidases

Stable storage: supplied as a solution in DMSO, allowing for long-term storage at -20°C

Consistent performance: ready-to-use solution

General description

Protease Inhibitor Cocktail for mammalian cell and tissue extracts, in DMSO solution. It contains six individual components for inhibiting serine, cysteine, and acid proteases, and aminopeptidases.

Other Notes

2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research
AEBSF
Aprotinin
Bestatin
E-64
Leupeptin
Pepstatin A

Preparation Note

One mL of this cocktail solution is recommended for the inhibition of endogenous enzymes found in 100 mL of lysate from 20 g of bovine liver or 10 mL of lysate from CHO cells. This product is supplied as a solution in DMSO.

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H315,H319

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2

Storage Class

10 - Combustible liquids

wgk

WGK 2

flash_point_f

188.6 °F - closed cup

flash_point_c

87 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000520598
0000520594
0000520594
0000520598
0000502558

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Megan D Schertzer et al.
Molecular cell, 75(3), 523-537 (2019-07-02)
Long noncoding RNAs (lncRNAs) cause Polycomb repressive complexes (PRCs) to spread over broad regions of the mammalian genome. We report that in mouse trophoblast stem cells, the Airn and Kcnq1ot1 lncRNAs induce PRC-dependent chromatin modifications over multi-megabase domains. Throughout the
Interaction of Huntington disease protein with transcriptional activator Sp1.
Li SH et al
Molecular and Cellular Biology, 22(5), 1277-1287 (2002)
Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor.
Dolci S et al
The Journal of Biological Chemistry, 276(43), 40225-40233 (2001)
A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.
Liu L et al
Neurobiology of Disease, 31(1), 46-57 (2008)
Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
Planel E et al
Faseb Journal, 23(8), 2595-2604 (2009)
View All Related Papers

Related Content

Multiplexed Evaluation of Soluble Immune-Checkpoint Molecules | MILLIPLEX® Assays

Research evaluating immune checkpoints may help identify those likely to benefit from PD-1/PD-L1 immunotherapy and reveal new immunotherapy targets for future investigation. See how the MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 2 was used to multiplex immune checkpoint molecules for NSCLC research.

プロテアーゼ阻害剤：サンプル調製中にタンパク質が失われないように

タンパク質の単離と特性解析におけるタンパク質分解を予防して、サンプル調製でタンパク質を保護するために、ニーズに応じてさまざまなプロテアーゼ阻害剤を選択しましょう。

Protease Inhibitor Selection: Avoid Protein Loss in Sample Prep

Select different protease inhibitor types based on your needs to prevent protein degradation during isolation and characterization and safeguard proteins in sample prep.

可溶性免疫チェックポイント分子のマルチプレックス評価 | MILLIPLEX® アッセイ

可溶性免疫チェックポイント分子の評価研究は、PD-1/PD-L1免疫療法が有効な患者の特定や、今後の免疫療法研究の新しいターゲットの発見に役立ちます。MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 2を用いたNSCLC研究のための免疫チェックポイント分子のマルチプレックス評価についてご覧ください。

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service